RxDoctor Payments Data

Maribeth Knight, DO

Internal Medicine · West Bloomfield, MINPI 1083681365

Payments from drug & device makers

$6,340in general payments, 2019–2025

Across 414 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Amgen$613
  • Pfizer$556
  • Lilly USA, LLC$506
  • AbbVie$414
  • AstraZeneca$336
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$6,24098%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,340 in reported general payments places this provider in the 90th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$105,085
Medicare patients
266
Services billed
1,132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide80$113,000
JardianceEmpagliflozin52$71,697
EliquisApixaban60$68,398
MounjaroTirzepatide32$34,573
RybelsusSemaglutide20$32,842
MyrbetriqMirabegron28$26,096
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$19,009
XareltoRivaroxaban11$12,672
AbrysvoRsv Vacc, Pref A And Pref B/Pf29$9,190
GemtesaVibegron11$7,115
Atorvastatin Calcium443$6,775
ShingrixVaricella-Zoster Ge/As01b/Pf30$6,669
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$4,396
Rosuvastatin Calcium265$4,350
Levothyroxine Sodium311$4,313

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,419$145,842100 claims
PfizerEliquis, Abrysvo$556$77,58789 claims
Boehringer IngelheimJardiance$147$71,69752 claims
Lilly USA, LLCMounjaro$506$34,57332 claims
Astellas Pharma US IncMyrbetriq$329$26,09628 claims
GSKTrelegy Ellipta, Shingrix$328$25,67845 claims
Sumitomo Pharma America, Inc.Gemtesa$23$7,11511 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$52$4,313311 claims
AbbVieSynthroid$414$3,28139 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,567 internal medicine providers in Michigan.

Other internal medicine in West Bloomfield

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →